<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04778111</url>
  </required_header>
  <id_info>
    <org_study_id>IRR-CLP-2021-3</org_study_id>
    <nct_id>NCT04778111</nct_id>
  </id_info>
  <brief_title>Segmental Exclusion of the Upper Limb and Peri-personal Space</brief_title>
  <acronym>EPPEX</acronym>
  <official_title>Segmental Exclusion of the Upper Limb and Peri-personal Space</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is based on previous studies on the search of the limit of the peri-personal&#xD;
      space. In a previous study, Gouzien et al. (2017) evaluated the peri-personal space of action&#xD;
      of patients with upper limb amputations and sought a link between this space and the level of&#xD;
      integration of their myoelectric prosthesis. We have decided to implement part of this&#xD;
      protocol to evaluate the peri-personal space for another population with upper limb patholog:&#xD;
      segmental exclusion of the upper limb.&#xD;
&#xD;
      Exclusion is a phenomenon that is very little studied but known to orthopedic surgeons and&#xD;
      physical medicine and rehabilitation physicians. It is characterized by the non-use or&#xD;
      underuse of a limb segment in the absence of central nervous system involvement. This&#xD;
      phenomenon is compared to peripheral neglect. Most of the time, the patient is unaware of his&#xD;
      disorder &quot;he forgets his finger without realizing it&quot;, but this phenomenon can be reversible&#xD;
      under verbal exhortation from a third party.&#xD;
&#xD;
      The aim of this study is to observe if there is a change in peri-personal space in patients&#xD;
      with unilateral segmental exclusion.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Delta-MRD</measure>
    <time_frame>During one evaluation session</time_frame>
    <description>Difference (in cm or in % of error) between actual maximum reachable distance and perceived maximum reachable distance</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Patients With Musculoskeletal Disorders of the Upper Limb With Symptoms of Exclusion</condition>
  <arm_group>
    <arm_group_label>Patients with exclusion</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Measurement of the actual and perceived maximum reachable distance</intervention_name>
    <description>A device (a table) will present luminous targets (green circles) to the subjects. Subjects will be asked to determine whether or not they are able to reach this target with their upper limb.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Patients with exclusion</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The patients included in this study are patients with upper extremity musculoskeletal&#xD;
        disorders of traumatic origin. To these disorders is added a segmental exclusion syndrome,&#xD;
        which is defined as the under-use or non-use of part of the upper limb.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult (age greater than or equal to 18 years old).&#xD;
&#xD;
          -  Person with a symptom of unilateral exclusion.&#xD;
&#xD;
          -  Person with no contraindication to hard work in activities of daily living due to the&#xD;
             lesions.&#xD;
&#xD;
          -  Person who has given informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Person under 18 years of age.&#xD;
&#xD;
          -  Person with visual impairment&#xD;
&#xD;
          -  A person with a central neurological pathology.&#xD;
&#xD;
          -  A person with cognitive impairment related to a brain injury, psychiatric illness or&#xD;
             intellectual disability.&#xD;
&#xD;
          -  A person who has difficulty understanding instructions.&#xD;
&#xD;
          -  A person of full age who is subject to a legal protection measure or who is unable to&#xD;
             give consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jonathan Pierret, PhD</last_name>
    <phone>03 83 52 67 61</phone>
    <email>jonathan.pierret@ugecam.assurance-maladie.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amélie Touillet, MD</last_name>
    <phone>03 83 52 67 61</phone>
    <email>amelie.touillet@ugecam.assurance-maladie.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut Régional de Médecine Physique et de Réadaptation</name>
      <address>
        <city>Nancy</city>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 26, 2021</study_first_submitted>
  <study_first_submitted_qc>February 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2021</study_first_posted>
  <last_update_submitted>February 26, 2021</last_update_submitted>
  <last_update_submitted_qc>February 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Musculoskeletal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

